Boxer Capital, LLC Centessa Pharmaceuticals PLC Transaction History

Boxer Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.99 - $17.54 $913,159 - $1.46 Million	-83,090 Reduced 6.23%	1,251,137 $14.1 Million
Q3 2021 Nov 15, 2021	BUY	$16.7 - $23.11 $7.18 Million - $9.94 Million	430,000 Added 47.55%	1,334,227 $22.3 Million
Q2 2021 Aug 16, 2021	BUY	$21.71 - $25.66 $19.6 Million - $23.2 Million	904,227 New	904,227 $20.1 Million

108

118M

5.9K

53K

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.59B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.